New Psychoactive Substances

Häftad, Engelska, 2026

730 kr

Kommande

Beskrivning

This book delves into the dynamic and increasingly complex world of New Psychoactive Substances (NPS). Between 2009 and 2023, more than 1,250 distinct NPS were identified worldwide, with a record number reported in 2023 alone. This surge reflects a growing diversity, particularly in the categories of synthetic opioids (notably nitazenes), cannabinoids, and stimulants. The emergence of these substances presents significant challenges for public health, law enforcement, and regulatory frameworks, largely due to their novel chemical structures, limited detectability, and serious health risks, including addiction, mental illness, and overdose. Drawing on the most recent scientific and clinical evidence, this book offers a comprehensive examination of the pharmacological, medical, social, and legal aspects of NPS, with a focus on practical strategies for prevention, diagnosis, and treatment in the field of addiction medicine.

Produktinformation

Utgivningsdatum:2026-09-20
Mått:158 x 236 x 9 mm
Vikt:254 g
Format:Häftad
Språk:Engelska
Antal sidor:168
Förlag:OUP USA
ISBN:9780190095697

Utforska kategorier

Klinisk medicin och internmedicin inom Medicin
Biovetenskap inom Naturvetenskap och teknik
Farmakologi inom Medicin

Mer om författaren

Kristina Adorjan, MD, Research Associate, Institute of Psychiatric Phenomics and Genomics, University Hospital, Munchen, Germany.Thomas G. Schulze, MD, Professor, Department of Psychiatry and Psychotherapy and Director, Institute of Psychiatric Phenomics and Genomics, Medical Center of the University of Munchen, Germany.Sharon L. Walsh, PhD, Professor of Behavioral Science and Director, Center on Drug and Alcohol Research, University of Kentucky, Lexington, Kentucky.

Innehållsförteckning

IntroductionKristina Adorjan, Sharon L. Walsh, Thomas G. Schulze Chapter 1. New psychoactive substances: definition and classificationKatarzyna Kuczynska and Jolanta B. Zawilska Chapter 2. The Pandemic of NPS in Society: an overview of the Social ContextElisabeth Prevete, Giuseppe Bersani and Ornella Corazza Chapter 3. Analytical and Biochemical Evaluation of New Psychoactive SubstancesJürg Gertsch Chapter 4. Stimulant NPS Fabrizio Schifano, John Martin Corkery, Valeria Catalani, Stefania Chiappini, Davide Arillotta, Alessandro Vento, Norbert Scherbaum, and Amira Guirguis Chapter 5. New psychoactive substances. Challenges, consequences and treatment approachesSynthetic Cannabinoid Receptor Agonists (SCRAs)Dr. Philippe Pfeifer and Dr. Katharina Elisabeth Grafinger Chapter 6. New Psychoactive Substances: HallucinogensLeila Soravia, Tobias Bracht, Niklaus Denier, Yasmin Schmid, and Felix Müller Chapter 7. Depressant NPS - Synthetic OpioidsVinz K. Schmid, Boris B. Quednow, and Saraliane Kroll Chapter 8. NPS related specialitiesKristiane Siste, Rama Kamal, Alexander Baldacchino, Hussien Elkholy, Roshan Bhad, Hamed Ekhtiari, Christian G. Schütz, and Sophia Achab Chapter 9. Concluding RemarksKristina Adorjan, Sharon L. Walsh, Thomas G. Schulze

Du kanske också är intresserad av

Tasman’s Psychiatry

Allan Tasman, Michelle B. Riba, Renato D. Alarcón, César A. Alfonso, Shigenobu Kanba, Dusica Lecic-Tosevski, David M. Ndetei, Chee H. Ng, Thomas G. Schulze

5 658 kr

Tasman's Psychiatry

Thomas G. Schulze, Chee H. Ng, David M. Ndetei, Dusica Lecic-Tosevski, Shigenobu Kanba, Cesar A. Alfonso, Renato D. Alarcon, Michelle B. Riba, Allan Tasman

E-bok

2024

5 974 kr

Suicide by Self-Immolation

Thomas G. Schulze, Prabha S. Chandra, Cesar A. Alfonso

E-bok

2021

1 408 kr

Tasman’s Psychiatry

Allan Tasman, Michelle B. Riba, Renato D. Alarcón, César A. Alfonso, Shigenobu Kanba, Dusica Lecic-Tosevski, David M. Ndetei, Chee H. Ng, Thomas G. Schulze

9 418 kr